ANGELA NGUYEN: Open Payments
NPI 1417678426 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 26 payments from 12 companies in 2025. Trend: 2023 $351 · 2024 $492 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 3 | $193 |
| Novartis Pharmaceuticals Corporation | 12 | $164 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Ionis Pharmaceuticals, Inc. | 1 | $36 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Amgen Inc. | 1 | $24 |
| BridgeBio Pharma, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: AMVUTTRA, LEQVIO, TRYNGOLZA, INSPIRE, JARDIANCE, VERQUVO, REPATHA, Attruby.
Industry payments across CA — which companies pay providers there.
